Skip to content
News

Guide to making a will: Your will counts

The Swiss Paediatric Oncology Group (SPOG) seeks to improve treatment and the quality of life for children and adolescents with cancer. SPOG offers a guide to bequests and legacies to assist individuals interested in using their assets for the specific purpose of doing good for others.

If you would like to stipulate who will inherit your estate or part of it, it is a good idea to make a will. Did you know that the Swiss legislation governing inheritance was changed recently? The revised inheritance legislation that has been in force since 1 January 2023 contains several changes. These include a reduction of the compulsory shares awarded to direct descendants from ¾ to ½ of the statutory share of the estate and removal of the compulsory share for parents. You may distribute the rest of your estate as you wish.

Why should I write a will? What is a gift? How do I decide who should be the executor of my estate?

There are many questions relating to a person’s last will and testament. This is why it is so important to tackle the question of inheritance and the distribution of assets at an early stage. The brochure available from SPOG can clarify matters and help you to gain a clear understanding of the ways in which you can put your assets to good use. And a glossary provides you with an overview of important related terms and definitions.

A legacy or a bequest in favour of SPOG can make an important contribution to improving the treatment and quality of life of children and adolescents with cancer. Take this opportunity to find out how you can make a donation of this type and order the guide from the SPOG website today (available in German or French).

I am also happy to provide advice in a personal discussion.

Published 04.01.2023
Share article 
Flora von Holzen
Flora von Holzen

Flora von Holzen is fully invested in fundraising and is in particular responsible for the institutional fundraising portfolio. The jurist also holds the position of Deputy Head Partner Relations.

More articles from Flora von Holzen

More articles